Follow The Filings

AVTR Avantor Inc.

Health Care, filed as AVANTOR INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 1

  • 1 Owner
  • #238
  • Max 4.6%
  • Master 0.10%
  • $367M
  • 1 reduce

In 2026 Q3 Greenhaven Associates trimmed Avantor.

Who owns this now

Largest portfolio weights among holders, up to 4.6% (Greenhaven Associates). Not free-float ownership.

  1. Greenhaven Associates Reduce 4.6%

Who owns AVTR

Sorted by value, long equity only, as of 2026 Q3.

History
Greenhaven Associates 4.6% Reduce −1.1% 24,359,610 $367M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by AVTR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AVTR insider trades
  • $8.7M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gregory T Lucier Director
    Buy
    $83K 10,000 shares at $8.32 +20% to stake
    Traded May 8 Filed May 11
    ↗
  2. Simon Dingemans Director
    Buy
    $204K 25,000 shares at $8.14 New stake
    Traded May 1 Filed May 5
    ↗
  3. Sanjeev K Mehra Director
    Buy
    $1M 125,000 shares at $8.01 +36% to stake
    Traded Mar 10 Filed Mar 11
    ↗
  4. Gregory T Lucier Director
    Buy
    $458K 50,000 shares at $9.16 New stake
    Traded Feb 19 Filed Feb 23
    ↗
  5. Gregory L Summe Director
    Buy
    $940K 100,000 shares at $9.40 +33% to stake
    Traded Feb 12 Filed Feb 12
    ↗
  6. Sanjeev K Mehra Director
    Buy
    $3.9M 350,000 shares at $11.09 New stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
    ↗
  7. Emmanuel Ligner CEO
    Buy
    $993K 87,500 shares at $11.35 +45% to stake
    Traded Nov 17, 2025 Filed Nov 17, 2025
    ↗
  8. Gregory L Summe Director
    Buy
    $1.1M 100,000 shares at $11.25 +50% to stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 stock grants and 18 share withholdings for taxes.

Congress

3 members of Congress traded AVTR in the last three years: 2 buys and 5 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Sell $1K–$15K Aug 13, 2025 filed Sep 12, 2025
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Aug 12, 2025 filed Sep 12, 2025
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Jul 23, 2025 filed Aug 14, 2025
  4. Lisa C. McClain R-MI-9Spouse Partial sale $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  5. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 11, 2025 filed Aug 13, 2025
  6. John James R-MI-10 Sell $1K–$15K Sep 4, 2024 filed Sep 6, 2024

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.97B $6.78B $6.55B
Gross profit $2.36B $2.28B $2.14B
Gross margin * 33.9% 33.6% 32.7%
Net income $321.1M $711.5M -$530.2M
Net margin * 4.6% 10.5% -8.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.38B $2.15B $2.45B
Total non-current assets * $10.59B $9.97B $9.34B
Total assets $12.97B $12.11B $11.79B
Total current liabilities $1.48B $2.01B $1.38B
Total non-current liabilities * $6.24B $4.15B $4.85B
Total equity $5.25B $5.96B $5.56B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $870M $840.8M $623.8M
Cash from investing -$143.7M $438.9M -$130.5M
Cash from financing -$0.844B -$1.28B -$0.409B
Net change in cash -$109.2M -$23M $103.6M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.